National Health Act 1953 - Amendment Rules under subsection 99AAA(8) 2011 (No. 1) (No. PB 13 of 2011)

Overview

The Amendment Rules under subsection 99AAA(8) 2011 (No.1) were enacted to address and correct typographical errors in the previous Amendment Rules under subsection 99AAA(8) 2010 (No.1). These amendments ensure the accuracy and functionality of the Rules concerning claims for payment in relation to the supply of pharmaceutical benefits under the National Health Act 1953. The Act, enacted in 1953, aims to facilitate the supply of pharmaceutical benefits and establish the procedures for making and processing claims related to these benefits. The rules were made by the Minister of Health under the authority of subsection 99AAA(8) of the Act, with the policy objective of maintaining and updating the accuracy and relevance of the rules governing the pharmaceutical benefits scheme. This legislative instrument aims to correct errors without substantially altering the existing arrangements and will commence on the day after registration on the Federal Register of Legislative Instruments.

Scope and Application

The Amendment Rules under subsection 99AAA(8) 2011 (No.1) are made pursuant to subsection 99AAA(8) of the National Health Act 1953 and amend the Rules concerning claims for payment in relation to the supply of pharmaceutical benefits. These rules apply to approved suppliers, including pharmacists and medical practitioners, authorised nurse practitioners, and authorised midwives, who supply pharmaceutical benefits to patients for treatment. The amendment primarily updates cross-references in the rules to the determination made under paragraph 98B(1)(a) of the Act, ensuring accuracy by replacing outdated references with current section numbers. Additionally, the Amendment Rules rectify a typographical error from a previous amendment by replacing references to "doctor’s bag order forms" with "emergency drug supply forms" and "prescriber" with "PBS prescriber". These amendments, which were intended to take effect on 1 December 2010, ensure that the procedures and terminology in the rules are consistent with the Act’s provisions and current practices. The rules apply nationally as they are amendments to the Commonwealth legislation and no exclusions or exemptions are specified in this particular instrument.

Key Provisions

The Amendment Rules under subsection 99AAA(8) of the National Health Act 1953 (the Act) (F2011L00162) make several amendments to the Rules concerning claims for payment in relation to the supply of pharmaceutical benefits. Section 2 of the Rules, which sets out the procedures for approved suppliers to follow when making claims for payment, is updated to ensure that references to the determination made under paragraph 98B(1)(a) of the Act (Commonwealth price for pharmaceutical benefits supplied by approved pharmacists) are accurate. Additionally, the term ‘doctor’s bag order forms’ is replaced with ‘emergency drug supply forms’ to reflect the broader range of healthcare professionals who can supply certain pharmaceutical benefits to patients for treatment. The term ‘prescriber’ is also replaced with ‘PBS prescriber’, which is the correct term defined in the Act. These amendments were initially made in a previous amendment to the Rules (PB 113 of 2010), but due to typographical errors, they had no legal effect and had to be remade. The Amendment Rules impose obligations on approved suppliers to ensure they follow the updated procedures when making claims for payment in relation to the supply of pharmaceutical benefits. Approved suppliers must provide accurate information to the Secretary, including details of the pharmaceutical benefits supplied, the amount claimed, and any supporting documentation. The Secretary, in turn, must process and determine the claims and make payments to the approved suppliers in accordance with the Rules. Failure to comply with the requirements set out in the Amendment Rules may result in civil or criminal consequences. Approved suppliers who fail to provide accurate information or follow the correct procedures may be subject to penalties, including fines and imprisonment. In addition, the Secretary may recover any overpayments made to approved suppliers who have failed to comply with the Rules. The maximum penalties for breaches of the Rules are not specified in the Amendment Rules, but they may be found in the National Health Act 1953 or other relevant legislation. In summary, the Amendment Rules under subsection 99AAA(8) of the National Health Act 1953 update the procedures for approved suppliers to follow when making claims for payment in relation to the supply of pharmaceutical benefits. These amendments ensure that approved suppliers provide accurate information and follow the correct procedures when making claims for payment, and that the Secretary processes and determines these claims in accordance with the Rules. Failure to comply with the requirements set out in the Amendment Rules may result in civil or criminal consequences, including fines and imprisonment.